2-(Chloromethyl)-4-methylquinazoline

We are 2-(Chloromethyl)-4-methylquinazoline CAS:109113-72-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-(Chloromethyl)-4-methylquinazoline
CAS.NO:109113-72-6
Synonyms:2-chloromethyl-4-methylquinazoline
2-chloromethyl-4-methylquinazoline
Molecular Formula:C10H9ClN2
Molecular Weight:192.64500
 
Physical and Chemical Properties:
Density:1.251
Melting point:61-63ºC
Boiling point:240.039ºC
Flash point:122.14ºC
 
HS Code: 2933499090
UN No.: UN3261
Hazard class: 8 categories 
Packing level: Class III
 
Specification:
Appearance:Light yellow powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Linagliptin
 
Note:The product under valid patents will not be offered to the countries covered by patents.

2-(Chloromethyl)-4-methylquinazoline


Related News: DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.897671-69-1 At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.135-63-7 At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4,6-bis(2-phenylpropan-2-yl)phenol CAS:70321-86-7 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.

Related Products
Product Name
4-fluorobutyl acetate View Details
Boc-N-alpha-methyl-O-benzyl-L-tyrosine View Details
1-BROMO-2-FLUORO-4-IODOBENZENE View Details
Methyl 2-cyano-2-methylpropanoate manufacturer 2,3-dihydro-1H-inden-2-amine manufacturer Isobutyryl chloride manufacturer 4-Methyl-benzylidene camphor manufacturer palmitoleic acid manufacturer